Once-monthly injection for weight loss in adults with obesity
Part of Hormones & metabolism clinical trials.
This study tests a new once-monthly injection, berobenatide, to see if it is safe and helps adults with obesity lose weight. It is for people in Japan who have obesity and related health problems like high blood pressure, high cholesterol, or type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a body mass index (BMI) of 27 or higher, with at least two weight-related health problems, or a BMI of 35 or higher with at least one weight-related health problem.
- You have at least one of these conditions: high blood pressure, high cholesterol, or type 2 diabetes or prediabetes.
- Your weight has not changed by more than 5% in the last 3 months.
- You do not have type 1 diabetes or other types of diabetes except type 2.
- You have no history of pancreatitis (inflammation of the pancreas), or a personal or family history of a rare thyroid cancer (medullary thyroid carcinoma) or a genetic condition called MEN-2.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a once-weekly injection called berobenatide to see if it helps adults with obesity lose weight and improve related health problems like high blood pressure, high cholesterol, or blood sugar issues. It is for people living in Japan.
This study tests an investigational medicine given once a month to help Chinese adults with overweight or obesity lose weight. It is a placebo-controlled trial, meaning some participants will receive a dummy injection, and the study will compare the effects.
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
This study tests a once-weekly medicine called PF-08653944 to see if it helps Chinese adults lose weight compared to a placebo (a pill with no active medicine). It may be an option if you have been unable to lose weight through diet alone.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests a new once-a-month medicine for people who have already been taking a weight-loss medication and want to keep the weight off. Participants will switch from their current medicine (semaglutide or tirzepatide) to the study drug.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.